Literature DB >> 11312352

Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera.

B M Ward1, B Moss.   

Abstract

We produced an infectious vaccinia virus that expressed the B5R envelope glycoprotein fused to the enhanced green fluorescent protein (GFP), allowing us to visualize intracellular virus movement in real time. Previous transfection studies indicated that fusion of GFP to the C-terminal cytoplasmic domain of B5R did not interfere with Golgi localization of the viral protein. To determine whether B5R-GFP was fully functional, we started with a B5R deletion mutant that made small plaques and inserted the B5R-GFP gene into the original B5R locus. The recombinant virus made normal-sized plaques and acquired the ability to form actin tails, indicating reversal of the mutant phenotype. Moreover, immunogold electron microscopy revealed that both intracellular enveloped virions (IEV) and extracellular enveloped virions contained B5R-GFP. By confocal microscopy of live infected cells, we visualized individual fluorescent particles, corresponding to IEV in size and shape, moving from a juxtanuclear location to the periphery of the cell, where they usually collected prior to association with actin tails. The fluorescent particles could be seen emanating from cells at the tips of microvilli. Using a digital camera attached to an inverted fluorescence microscope, we acquired images at 1 frame/s. At this resolution, IEV movement appeared saltatory; in some frames there was no net movement, whereas in others movement exceeded 2 microm/s. Further studies indicated that IEV movement was reversibly arrested by the microtubule-depolymerizing drug nocodazole. This result, together with the direction, speed, and saltatory motion of IEV, was consistent with a role for microtubules in intracellular transport of IEV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312352      PMCID: PMC114235          DOI: 10.1128/JVI.75.10.4802-4813.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein.

Authors:  B M Ward; B Moss
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Functional cooperation between the microtubule and actin cytoskeletons.

Authors:  B L Goode; D G Drubin; G Barnes
Journal:  Curr Opin Cell Biol       Date:  2000-02       Impact factor: 8.382

3.  Secretory pathway kinetics and in vivo analysis of protein traffic from the Golgi complex to the cell surface.

Authors:  K Hirschberg; J Lippincott-Schwartz
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

4.  Live-cell analysis of a green fluorescent protein-tagged herpes simplex virus infection.

Authors:  G Elliott; P O'Hare
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail.

Authors:  F G da Fonseca; E J Wolffe; A Weisberg; B Moss
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles.

Authors:  C M Sanderson; M Hollinshead; G L Smith
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

7.  Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling.

Authors:  F Frischknecht; V Moreau; S Röttger; S Gonfloni; I Reckmann; G Superti-Furga; M Way
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

8.  The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles.

Authors:  H van Eijl; M Hollinshead; G L Smith
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

9.  Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation.

Authors:  S Röttger; F Frischknecht; I Reckmann; G L Smith; M Way
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

10.  Vaccinia virus infection disrupts microtubule organization and centrosome function.

Authors:  A Ploubidou; V Moreau; K Ashman; I Reckmann; C González; M Way
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

View more
  74 in total

Review 1.  Directed egress of animal viruses promotes cell-to-cell spread.

Authors:  David C Johnson; Mary T Huber
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Identification of second-site mutations that enhance release and spread of vaccinia virus.

Authors:  Ehud Katz; Elizabeth Wolffe; Bernard Moss
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.

Authors:  Zhenping Wang; Yuping Lai; Jamie J Bernard; Daniel T Macleod; Anna L Cogen; Bernard Moss; Anna Di Nardo
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

4.  Investigation of structural and functional motifs within the vaccinia virus A14 phosphoprotein, an essential component of the virion membrane.

Authors:  Jason Mercer; Paula Traktman
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

5.  Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein.

Authors:  Ehud Katz; Brian M Ward; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.

Authors:  Barbara Müller; Jessica Daecke; Oliver T Fackler; Matthias T Dittmar; Hanswalter Zentgraf; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

7.  Increased interaction between vaccinia virus proteins A33 and B5 is detrimental to infectious extracellular enveloped virion production.

Authors:  Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

8.  The A33-dependent incorporation of B5 into extracellular enveloped vaccinia virions is mediated through an interaction between their lumenal domains.

Authors:  Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

9.  There is an A33-dependent mechanism for the incorporation of B5-GFP into vaccinia virus extracellular enveloped virions.

Authors:  Winnie M Chan; Brian M Ward
Journal:  Virology       Date:  2010-04-07       Impact factor: 3.616

10.  Development and comparison of a quantitative TaqMan-MGB real-time PCR assay to three other methods of quantifying vaccinia virions.

Authors:  Jonathon L Baker; Brian M Ward
Journal:  J Virol Methods       Date:  2013-11-08       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.